Sign inJoin waitlistJoin the waitlist

Richard Chao

Anesthesiology Residency · New York Presbyterian Hospital

Credentials: ·

History

Anesthesiology
New York Presbyterian Hospital
2026–Present
FORDHAM UNIV, NEW YORK
2021–2025
Fordham University

Research

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Case report · Cancer Discovery · 2020 · 1,061 citations
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
New England Journal of Medicine · 2022 · 871 citations
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)
Journal of Clinical Oncology · 2022 · 277 citations

Lyudmila Bazhenova
6 papers
MJ
Melissa Johnson
5 papers
Pasi Jänne
5 papers
XY
Xiaohong Yan
5 papers
SO
Sai-Hong I Ou
4 papers
AS
Alexander Spira
3 papers
Keith Eaton
3 papers
KP
Kyriakos Papadopoulos
3 papers
Rebecca Heist
3 papers
Sanjay Goel
3 papers
Shubham Pant
3 papers
Theresa Werner
3 papers

Clinical trials

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer
Study director · Completed · Phase 1
Mirati Therapeutics Inc.
2014–2022